Skip to main content
Clinical Trials/ISRCTN16052610
ISRCTN16052610CompletedNot Applicable

Vasomotor symptoms (VMS) and endothelial function: A randomised placebo-controlled trial of oral micronised Progesterone (Prometrium ®)

Centre for Menstrual Cycle and Ovulation Research (CeMCOR) (Canada)0 sites165 target enrollmentStarted: May 10, 2005Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
165

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
Female

Inclusion Criteria

  • Women past menopause who are between one and ten years of their last menstrual period, not on any hormones for at least the past 6 months, experiencing hot flushes or night sweats and without any history or risk factors of heart disease (smoking, overweight, high lipid levels).

Exclusion Criteria

  • Amendment to protocol as of 17/05/2006:
  • 1. Any menstruation in the preceding year
  • 2. History of hysterectomy without ovariectomy unless she is 60 years of age
  • 3. Use of ovarian hormone therapy (estrogen, progestin, progesterone or androgen) in the preceding six months
  • 4. Any risk factors for heart disease like smoker, high blood pressure, high cholesterol, diabetes, overweight, and history of angina or abnormal electrocardiogram (ECG)

Investigators

Sponsor
Centre for Menstrual Cycle and Ovulation Research (CeMCOR) (Canada)

Similar Trials